Monday's violent selloff could be the prelude to a more volatile second half, but strategists still expect the S&P 500 to gain.» Read More
Plus, Cramer makes the call on retail, health care and more.
Following are the day’s biggest winners and losers. Find out why shares of eBay and General Motors popped while ConocoPhillips and Steel Dynamics dropped.
The president’s more concerned with retribution than recovery, Cramer says.
Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.
The Dow and S&P slumped to 11-year lows on Monday as investors lost faith that the U.S. government will be able to stabilize the financial system.
The Dow slid within striking distance of its bear-market low on Tuesday, despite the fact that President Obama signed the economic stimulus into law. What went wrong?
This company has heart, Cramer says. Find out how BSX fought its way off the operating table.
Rob Morgan of Clermont Wealth Strategies got some encouragement from President Obama's remarks about stimulus and recovery, but not enough to make him bullish on financials. That's not to say he's completely down on stocks.
It’s easy to like a company that, even in this environment, is focused on taking share.
Intuitive Surgical, a California company that makes endoscopic instruments, is running higher along with heavy options activity amid takeover rumors.
Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.
Boston Scientific is fighting to break out of its recent trading range as a large block of puts changes hands. BSX opened today by more than 2 percent from its close of $7.60 yesterday... The put activity coincides with a company setback in its protracted court battle with Johnson & Johnson.
The Dow fell for the fourth day in a row as concerns about massive losses at Citigroup knocked its shares 17 percent lower, dragging down bank stocks...
Options traders Tuesday are betting on more upside in medical technology company Stryker. Following heavy volume yesterday, SYK continues to see activity at the January 40 calls...
Cramer makes the call on viewers' favorite stocks.
Things look worse for GM, Ford and Chrysler Wednesday as Congress seems less likely to approve a $25 billion automaker bailout. Stocks slipped — but some analysts say that slide had little to do with the Big 3. CNBC canvassed the experts, who foresee plunging oil prices, a stronger dollar — and say the market has already bottomed (!).
There are reports of booze, women and beads--as in Mardi Gras beads. Specifically, the piece cites allegations from a lawsuit brought by a former MDT attorney who says the medical device maker sponsored a "discussion group" outing to New Orleans.
A first-of-its-kind study shows that putting hundreds of thousands of American heart patients on drugs instead of giving them a stent could save the country billions of dollars a year.
Not too long ago, some had written off the potential for significant growth to resume in sales of the little wire mesh tubes that are painted with special drugs to help keep arteries from reclogging.
The Lightning Round is extended in this CNBC.com exclusive feature.